AI Article Synopsis
- The study aimed to assess the safety and effectiveness of acupoint autohemotherapy (AA) in combination with Western medicine for treating chronic obstructive pulmonary disease (COPD).
- A meta-analysis of controlled trials indicated that combining AA with Western therapy improved clinical outcomes, including better lung function and increased exercise capacity in COPD patients.
- Despite these positive results, the authors caution that further research with larger and higher-quality randomized controlled trials is needed to confirm these findings due to the limited quality and number of studies included.
Article Abstract
Objective: To evaluate the safety and efficacy of acupoint autohemotherapy（AA）.
Methods: We collected Controlled Trials that are random of AA plus medicine of the west therapy vs western medicine therapy alone in treating COPD from PubMed, the Cochrane library, EMBASE, CNKI, CBM SinoMed, China Science, and Wanfang Data from database inception to July 1, 2019. Meta-analysis was performed using the RevMan 5.3.
Results: This meta-analysis identified that the combined treatment could enhance the total effective clinical rate, the forced expiratory volume in 1 s（FEV1）and forced vital capacity（FVC），increase the 6-min walking distance，and improve the self-assessment of chronic obstructive pulmonary disease score（CAT）.
Conclusion: The clinical effects of AA plus medicine of the west therapy are better than that of western medicine alone in treating COPD. However, due to the small number and poor quality of the included RCTs，this conclusion needs to be verified with larger samples and higher quality RCTs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ctcp.2021.101336 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!